149 related articles for article (PubMed ID: 38726878)
1. POLARIS: efficacy and safety of a vaginal medical device in recurrent bacterial vaginosis-a multicenter, open-label, non-controlled, study with 10 months of follow-up.
Murina F; Inghirami P; Biriș M; Sîrbu D; Barattini DF; Ardolino LI; Mangrella M; Casolati E; Roșu SM; Crișan C
J Int Med Res; 2024 May; 52(5):3000605241239021. PubMed ID: 38726878
[TBL] [Abstract][Full Text] [Related]
2. Performance and Safety of a New Medical Device (Polybactum) for Reducing the Recurrence Rate of Bacterial Vaginosis: Protocol for a Multicenter, Open-Label, Noncontrolled International Clinical Trial (POLARIS Study).
Murina F; Inghirami P; Biriș M; Sîrbu D; Barattini DF; Sbrocca F; Ardolino LI; Mangrella M; Casolati E; Roșu S; Crișan CD
JMIR Res Protoc; 2023 Jul; 12():e42787. PubMed ID: 37471117
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a novel vaginal medical device in recurrent bacterial vaginosis: a multicenter clinical trial.
Murina F; Crișan C; Biriș M; Sîrbu D; Barattini DF; Ardolino LI; Casolati E
Minerva Ginecol; 2020 Oct; 72(5):292-298. PubMed ID: 33325675
[TBL] [Abstract][Full Text] [Related]
5. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
[TBL] [Abstract][Full Text] [Related]
6. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
[TBL] [Abstract][Full Text] [Related]
7. Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study.
Ratten LK; Plummer EL; Murray GL; Danielewski J; Fairley CK; Garland SM; Hocking JS; Tachedjian G; Chow E; Bradshaw CS; Vodstrcil LA
BJOG; 2021 Mar; 128(4):756-767. PubMed ID: 33480468
[TBL] [Abstract][Full Text] [Related]
8. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
[TBL] [Abstract][Full Text] [Related]
9. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
[TBL] [Abstract][Full Text] [Related]
10. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
[TBL] [Abstract][Full Text] [Related]
11. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
[TBL] [Abstract][Full Text] [Related]
12. The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics.
Ling Z; Liu X; Chen W; Luo Y; Yuan L; Xia Y; Nelson KE; Huang S; Zhang S; Wang Y; Yuan J; Li L; Xiang C
Microb Ecol; 2013 Apr; 65(3):773-80. PubMed ID: 23250116
[TBL] [Abstract][Full Text] [Related]
13. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria.
Mitchell CM; Hitti JE; Agnew KJ; Fredricks DN
BMC Infect Dis; 2009 Jun; 9():89. PubMed ID: 19515236
[TBL] [Abstract][Full Text] [Related]
14. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
Front Immunol; 2021; 12():730986. PubMed ID: 34594336
[TBL] [Abstract][Full Text] [Related]
15. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
Heczko PB; Tomusiak A; Adamski P; Jakimiuk AJ; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M; Strus M
BMC Womens Health; 2015 Dec; 15():115. PubMed ID: 26635090
[TBL] [Abstract][Full Text] [Related]
16. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
Verwijs MC; Agaba SK; Darby AC; van de Wijgert JHHM
Am J Obstet Gynecol; 2020 Feb; 222(2):157.e1-157.e13. PubMed ID: 31404542
[TBL] [Abstract][Full Text] [Related]
17. High-dose vaginal maintenance metronidazole for recurrent bacterial vaginosis: a pilot study.
Aguin T; Akins RA; Sobel JD
Sex Transm Dis; 2014 May; 41(5):290-1. PubMed ID: 24722380
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study.
Ya W; Reifer C; Miller LE
Am J Obstet Gynecol; 2010 Aug; 203(2):120.e1-6. PubMed ID: 20659602
[TBL] [Abstract][Full Text] [Related]
19. Treatment considerations for bacterial vaginosis and the risk of recurrence.
Chen JY; Tian H; Beigi RH
J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
[TBL] [Abstract][Full Text] [Related]
20. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
